Goldman, Jennifer L. http://orcid.org/0000-0001-6628-8949
Miller, Jenna O.
Miller, Neil http://orcid.org/0000-0002-6151-4780
Eveleigh, Robert
Gibson, Andrew
Phillips, Elizabeth J.
Pastinen, Tomi
Funding for this research was provided by:
Foundation for the National Institutes of Health (R01GM129783)
Article History
Received: 23 July 2021
Revised: 17 December 2021
Accepted: 11 January 2022
First Online: 16 February 2022
Competing interests
: EJP reports grants from National Institutes of Health (P50GM115305, R01HG010863, R01AI152183, R21AI139021, U01AI154659) and from the National Health and Medical Research Council of Australia. She receives Royalties from Uptodate and consulting fees from Janssen, Vertex, Biocryst and Regeneron. She is co-director of IIID Pty Ltd that holds a patent for <i>HLA-B*57:01</i> testing for abacavir hypersensitivity, and has a patent pending for Detection of Human Leukocyte Antigen-A*32:01 in connection with Diagnosing Drug Reaction with Eosinophilia and Systemic Symptoms without any financial remuneration and not directly related to the submitted work.